Expired European patentEurope
Amide derivatives
EP 1163237 B1 · Applicant: AstraZeneca AB
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 13, 2000 and granted May 6, 2004. A European patent lasts at most 20 years from filing, so its term ended March 13, 2020.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 13, 2025.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 13, 2000
PublishedDecember 19, 2001
GrantedMay 6, 2004
Term endedMarch 13, 2020
Application numberEP 00909498
Classification (CPC)A61P1/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.